LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -638.02%-35.87M | 52.77%114.58M | 32.25%80.35M | 33.70%225.03M | 18.73%94.13M | -136.89%-4.86M | 47.29%75.01M | 143.69%60.76M | 141.45%168.31M | 149.86%79.28M |
Net income from continuing operations | 41.55%38.02M | 380.35%38.59M | 487.86%32.09M | 143.22%49.89M | 224.01%23.26M | 140.98%26.86M | 165.20%8.03M | 55.98%-8.27M | -0.23%-115.44M | 39.79%-18.76M |
Depreciation and amortization | 32.51%6.97M | 29.10%6.44M | 17.90%6.09M | 15.20%21.65M | 12.31%6.23M | 16.14%5.26M | 15.25%4.99M | 17.86%5.17M | 52.06%18.79M | 75.19%5.55M |
Deferred tax | 219.96%673K | -854.17%-687K | 751.19%715K | 70.78%-722K | 90.79%-173K | 1.92%-561K | 68.28%-72K | -59.22%84K | ---2.47M | ---1.88M |
Other non cash items | -0.72%1.66M | 1.60%1.65M | -10.17%1.67M | 61.72%6.81M | 21.45%1.66M | 68.76%1.67M | 73.37%1.62M | 102.18%1.86M | 1,075.70%4.21M | 783.00%1.37M |
Change In working capital | -119.23%-87.49M | 22.29%60.52M | -31.19%31.45M | -4.55%118.95M | 17.89%63.66M | -13,628.81%-39.91M | 7.98%49.49M | 86.68%45.71M | 5.95%124.61M | 39.14%54M |
-Change in receivables | 151.30%485K | -1,624.24%-503K | -145.89%-95K | -84.55%643K | -77.49%210K | -78.88%193K | -99.27%33K | 109.43%207K | 198.91%4.16M | 177.81%933K |
-Change in prepaid assets | -88.11%-6.31M | 337.59%2.98M | 25.45%-1.82M | -58.32%-10.01M | 20.55%-2.96M | 59.51%-3.36M | -344.25%-1.25M | -147.25%-2.44M | 61.02%-6.32M | 58.45%-3.72M |
-Change in payables and accrued expense | -63.88%-109.19M | 67.94%49.18M | 3.04%33.23M | 11.72%38.24M | 51.69%43.33M | -218.36%-66.62M | 36.42%29.28M | 529.39%32.25M | -33.53%34.23M | 42.22%28.56M |
-Change in other current liabilities | -11.11%-1.54M | -0.80%-1.39M | -202.78%-1.37M | -16.29%-2.73M | -357.40%-1.29M | -20.52%-1.39M | -62.90%-1.38M | 257.09%1.33M | ---2.35M | --500K |
-Change in other working capital | -7.05%29.06M | -55.01%10.26M | -89.51%1.51M | -2.20%92.8M | -12.12%24.36M | 5.11%31.26M | 12.95%22.81M | -16.60%14.37M | 9.64%94.89M | -4.00%27.72M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -638.02%-35.87M | 52.77%114.58M | 32.25%80.35M | 33.70%225.03M | 18.73%94.13M | -136.89%-4.86M | 47.29%75.01M | 143.69%60.76M | 141.45%168.31M | 149.86%79.28M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 296.73%121.54M | 102.76%204K | 151.83%26.23M | 95.69%-15.51M | 103.62%11.86M | 286.61%30.64M | 24.82%-7.4M | -798.37%-50.61M | 10.81%-359.59M | -296.16%-327.71M |
Net PPE purchase and sale | 49.37%-2.04M | 47.02%-4.44M | 70.50%-2.78M | 18.52%-25.56M | 55.00%-3.73M | 48.66%-4.04M | 13.44%-8.38M | -70.07%-9.41M | -11.42%-31.36M | -35.75%-8.29M |
Net intangibles purchase and sale | --0 | -37.33%-103K | -1,435.71%-215K | -6.42%-580K | -115.79%-451K | 49.37%-40K | 52.23%-75K | 86.00%-14K | 33.70%-545K | -91.74%-209K |
Net business purchase and sale | ---- | ---- | ---- | ---3.75M | --0 | ---- | ---- | ---- | --0 | --0 |
Net investment purchase and sale | 221.33%123.59M | 348.25%4.75M | 170.95%29.22M | 104.39%14.38M | 105.02%16.04M | 553.60%38.46M | --1.06M | ---41.18M | -9.82%-327.69M | -47,471.83%-319.21M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 296.73%121.54M | 102.76%204K | 151.83%26.23M | 95.69%-15.51M | 103.62%11.86M | 286.61%30.64M | 24.82%-7.4M | -798.37%-50.61M | 10.81%-359.59M | -296.16%-327.71M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -308.18%-92.09M | -93.52%-139.82M | -1,012.90%-101.27M | -341.97%-216.01M | -172.58%-112.09M | -204.13%-22.56M | -21,597.90%-72.25M | -9.1M | -109.71%-48.87M | -6,295.49%-41.12M |
Net common stock issuance | -581.60%-75.16M | -68.56%-65.11M | -1,211.87%-84.89M | -1,240.12%-69.67M | -4,461.95%-13.55M | -139.46%-11.03M | -12,905.39%-38.63M | ---6.47M | -101.03%-5.2M | 54.79%-297K |
Cash dividends paid | -30.90%-13.93M | -168.99%-48.67M | -39,773.53%-13.56M | -228.66%-125.2M | -153.13%-96.42M | ---10.64M | ---18.1M | ---34K | ---38.09M | -1,022.80%-38.09M |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Net other financing activities | -236.14%-3M | -67.65%-26.04M | -8.90%-2.83M | -278.70%-21.14M | 22.43%-2.12M | 68.33%-891K | ---15.53M | ---2.6M | -15.52%-5.58M | 33.57%-2.73M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -308.18%-92.09M | -93.52%-139.82M | -1,012.90%-101.27M | -341.97%-216.01M | -172.58%-112.09M | -204.13%-22.56M | -21,597.90%-72.25M | ---9.1M | -109.71%-48.87M | -6,295.49%-41.12M |
Net cash flow | ||||||||||
Beginning cash position | -34.64%42.71M | -3.21%67.72M | -9.41%62.4M | -77.72%68.88M | -80.86%68.59M | -82.29%65.34M | -78.69%69.97M | -77.72%68.88M | 122.26%309.13M | -0.61%358.41M |
Current changes in cash | -299.32%-6.41M | -438.97%-25.04M | 403.99%5.3M | 97.30%-6.48M | 97.89%-6.11M | 130.17%3.22M | -111.40%-4.65M | -94.55%1.05M | -241.34%-240.16M | -460.78%-289.55M |
Effect of exchange rate changes | --0 | 0.00%16K | -40.00%21K | 98.82%-1K | -468.18%-81K | 7.41%29K | 119.05%16K | 170.00%35K | -163.91%-85K | -83.46%22K |
End cash Position | -47.08%36.3M | -34.64%42.71M | -3.21%67.72M | -9.41%62.4M | -9.41%62.4M | -80.86%68.59M | -82.29%65.34M | -78.69%69.97M | -77.72%68.88M | -77.72%68.88M |
Free cash flow | -324.30%-37.91M | 65.35%110.04M | 50.70%77.36M | 45.82%198.9M | 27.08%89.95M | -270.61%-8.94M | 61.98%66.55M | 165.99%51.33M | 234.84%136.4M | 177.41%70.78M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |